FDA 483 - I3 PHARMACEUTICALS LLC - May 22, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
I 3 Pharmaceuticals, LLC in Warminster, PA, was cited for two observations during an FDA inspection from May 18-22, 2026. The firm failed to properly design and maintain equipment, including an unqualified modification to a packaging line, and lacked written procedures for its use. Additionally, the quality control unit did not follow its own procedures, leading to delayed investigations of out-of-limit microbiological results and the release of affected drug product without proper review.
ID · af8b41cd-2464-4cb5-ac06-7a1c7a3a071d